Hayao

Harbin Pharmaceutical Group Holding Co., Ltd. (also known as Hayao or HPGC) is a leading pharmaceutical company based in China. Established in 1996, the company has grown to become one of the country's largest and most influential pharmaceutical enterprises. It is headquartered in Harbin, Heilongjiang Province, China.

HPGC is primarily engaged in the research, development, manufacturing, and distribution of a wide range of pharmaceutical products. Its product portfolio includes prescription drugs, over-the-counter medicines, traditional Chinese medicines, healthcare products, and medical devices. The company focuses on various therapeutic areas, such as cardiovascular, central nervous system, anti-infective, and respiratory.

With a commitment to innovation and quality, Harbin Pharmaceutical Group invests significantly in research and development to bring new and effective drugs to the market. It also emphasizes international collaborations and partnerships to expand its global presence.

Moreover, HPGC places a strong emphasis on social responsibility and sustainable development. It actively participates in various charitable activities and strives to contribute positively to the healthcare industry and society at large.

Founded: 1996

Founder: Harbin Pharmaceutical Group Co., Ltd.

Headquarters: Harbin, Heilongjiang, China

Website: http://www.hayao.com/